BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
University of Melbourne
Melbourne, AustraliaPublicacions en col·laboració amb investigadors/es de University of Melbourne (5)
2023
-
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia
Future Oncology, Vol. 19, Núm. 5, pp. 345-353
-
SARS-CoV-2 Infection in Patients with Waldenstrom's Macroglobulinemia: A Multicenter International Cohort Study
HemaSphere
2020
-
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
Blood, Vol. 136, Núm. 18, pp. 2038-2050
2016
-
Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
British Journal of Haematology, Vol. 175, Núm. 1, pp. 77-86
2010
-
International network of cancer genome projects
Nature, Vol. 464, Núm. 7291, pp. 993-998